RESULTS
One hundred and eighty-eight adults, children, and infants were successfully screened, from whom 106 participants were enrolled and received injections. Age groups were enrolled sequentially in the following order (for safety reasons): 18–35 years, 36–61 years, 11–17 years, 6–10 years, 1–5 years, and 6–11 months (